Share this article on:

Case Series Analysis of Myopic Progression Control With a Unique Extended Depth of Focus Multifocal Contact Lens

Cooper, Jeffrey, M.S., O.D.; O'Connor, Brett, O.D.; Watanabe, Ronald, O.D.; Fuerst, Randall, O.D.; Berger, Sharon, O.D.; C.O.V.D.; Eisenberg, Nadine, O.D.; Dillehay, Sally M., Ed.D., O.D.

doi: 10.1097/ICL.0000000000000440
Article: PDF Only

Objectives: To determine the rate of myopia progression in children fit with a commercially available extended depth of focus (center distance) multifocal soft contact lens with attributes theoretically expected to slow the progression of myopia.

Methods: A retrospective case series analysis of 32 patients (ages 6–19 years, mean 10.98±2.95) from 10 practice locations was performed. At initial presentation, 44% wore spectacles, 37.5% spherical soft contact lenses, 15.6% a different soft multifocal contact lens, and 3% orthokeratology lenses. All participants showed progression of at least −0.50 diopter with current corrections and were fit with an extended depth of focus (center distance) multifocal soft contact lens (NaturalVue Multifocal 1 Day Contact Lenses; Visioneering Technologies, Inc., Alpharetta, GA). Follow-up time was 6 to 25 months (mean: 10.94±4.76).

Results: Reductions in the annualized rate of myopic progression from −0.85 D per year ±0.43 D to −0.04 D per year ±0.18 D (P<0.00000) OD, −0.90 D per year ±0.57 D to −0.03 D per year ±0.17 D (P<0.00000) OS were observed. These data represent a reduction of 95.4% OD and 96.25% OS. Approximately 98.4% of the children showed reduction of annualized myopic progression; 91% showed a decrease of 70% or greater. Overall, 81.25% showed complete halting of myopic progression, including 6.25% demonstrating myopic regression.

Conclusions: This unique extended depth of focus (center distance) daily disposable multifocal contact lens was effective in slowing myopic progression in these children. These findings add to the growing evidence that center distance multifocal soft contact lenses may slow the progression of myopia.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Professor Emeritus (J.C.), State University of New York College of Optometry, New York, NY; Pullen Eye Care (B.O.), Jacksonville, FL; New England College of Optometry (R.W.), Boston, MA; EYECenter Optometric (R.F.), Orangevale, CA; Roswell Eye Clinic (S.B.), Roswell, GA; Cooper Eye Care (N.E.), New York, NY; and Visioneering Technologies, Inc. (S.M.D.), Alpharetta, GA.

Address correspondence to Jeffrey Cooper, M.S., O.D., 539 Park Avenue, New York, NY 10065; e-mail: cooperjsc1@gmail.com

J. Cooper: consultant to VTI, Treehouse Eyes, and Magic Leap; B. O'Connor: consultant to VTI; R. Watanabe: none declared; R. Fuerst: none declared; S. Berger: none declared; N. Eisenberg: none declared; and S. M. Dillehay: employee of VTI.

Accepted August 28, 2017

© 2018 Contact Lens Association of Ophthalmologists, Inc.